{"id":"NCT00255125","sponsor":"VA Office of Research and Development","briefTitle":"Role of Soy Supplementation in Prostate Cancer Development","officialTitle":"Role of Soy Isoflavones in Prostate Cancer Prevention","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2009-04","completion":"2009-10","firstPosted":"2005-11-17","resultsPosted":"2015-06-17","lastUpdate":"2019-06-18"},"enrollment":86,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Prostate Neoplasm"],"interventions":[{"type":"DRUG","name":"Soy Supplement","otherNames":["Fla-vien"]},{"type":"DRUG","name":"Placebo","otherNames":["No other name"]}],"arms":[{"label":"Arm Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Arm Soy Supplement","type":"EXPERIMENTAL"}],"summary":"This is a randomized study evaluating the effectiveness and direct effect a commercial soy supplement has on prostate cancer and normal prostate tissue. Patient will be randomized it either receive placebo or a commercial soy supplement for 2-4 weeks prior to the planned surgery for treatment of their prostate cancer. Patient's blood and prostate tissue will be evaluated to determine the effects of the soy supplement on the prostate tissue.","primaryOutcome":{"measure":"Effect of Soy Isoflavones on Serum Testosterone Levels.","timeFrame":"Two weeks","effectByArm":[{"arm":"Arm Soy Supplement","deltaMin":376,"sd":null},{"arm":"Arm Placebo","deltaMin":405,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["23874588"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":42},"commonTop":["GI symptoms"]}}